3:1 Bonus Share, Rs 4/Share Dividend: Pharma Co Sets Record Date For Bonus Issue, Eligible?

Pharmaceuticals sector company Remus Pharmaceuticals fixed June 6, 2024 as the record date for 3:1 bonus share. It implies shareholders will become eligible to receive 3 bonus shares for every 1 share held as on June 6, 2024. Earlier in April 2024, Remus Pharmaceuticals recommended 2nd interim dividend of Rs 4/share with face value of Rs 10/- each for financial year 2023-24.

Remus Pharmaceuticals has yet to declared record date for dividend. Remus Pharmaceuticals shares declined over 7% in last 1-month and soared more than 19% in last 3-months. More details below:

Remus Pharmaceuticals Sets Record Date For Bonus Share: As per the regulatory filing of Remus Pharmaceuticals dated May 23, 2024, "Pursuant to the provisions of Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company has fixed Thursday, June 06, 2024 as 'Record Date' for the purpose of determining the eligibility of Shareholders for the entitlement of issue of Bonus Equity Shares in the ratio of 3: 1 i.e. 3(Three) new fully paid-up Equity Shares of Rs 10/- (Rupees Ten only) each for every 1 (One) existing fully paid-up Equity Share of Rs 10/ (Rupees Ten only) each held by them on the Record Date. The Bonus Equity Shares shall be allotted to the Equity Shareholders whose names appear in the Register of Members I List of Beneficial Owners as on the said Record Date."

Remus Pharmaceuticals Interim Dividend: According to the NSE filing of the company dated April 23, "declared 02nd interim dividend of Rs. 04/- (Rupees Four only) per equity share having face value of Rs. 10/- each for the financial year 2023-24."

Remus Pharmaceuticals Share Performance: The 52-week high price of Remus Pharmaceuticals share on BSE is Rs 8747.00 apiece (as on April 25, 2024) and 52-week low price is Rs 1711.25 per share (as May 29, 2023), respectively. The company's market capitalisation is Rs 1120.95 crores. In last 1-week, Remus Pharmaceuticals shares fell over 2%, fell over 7% in last 1-month, and offered return of over 19% in last 3-months.

How To Be Eligible For Bonus Dividend of Remus? Record date is important in deciding eligibility of shareholders for obtaining dividend and bonus shares. Individuals whose name appear in company's shareholders record as on the record date will become eligible to earn dividend, bonuses declared by the company. Record date is the particular day on which a company confirms the list of shareholders eligible for its dividend distribution. Remus fixed June 6 as the record date for bonus share and yet to declared record date for interim dividend.

About: Remus focuses on marketing, distributing and exporting top-of-the-line complex generics certified by regulatory authorities. Backed by expert scientists, it makes "healing through medicines" globally affordable. For over a decade, Remus has been at the forefront of critical healthcare globally, according to its official website.

Disclaimer: The stock highlights the dividend, bonus share and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.